Patents by Inventor Goran Claeson

Goran Claeson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6313096
    Abstract: Pharmaceutical compositions comprising compounds of the formula: in which X=H or is an N-protecting group; Y is 1-10 á-amino acids; Q1 and Q2 taken together represent the residue of a diol; R is C1-4alkyl; and the asymmetric carbon atom marked * may have the D- or L-configuration, are useful in therapeutic methods of inhibiting thrombin.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: November 6, 2001
    Assignee: Trigen Limited
    Inventors: Goran Claeson, Manfred Hans Wilhelm Philipp
  • Patent number: 6114308
    Abstract: Pharmaceutical compositions comprising compounds of the formula: ##STR1## in which X.dbd.H or is an N-protecting group; Y is 1-10 .alpha.-amino acids; Q1 and Q2 taken together represent the residue of a diol; R is C.sub.1-4, alkyl; and the asymmetric carbon atom marked * may have the D- or L-configuration, are useful in therapeutic methods of inhibiting thrombin.
    Type: Grant
    Filed: May 14, 1998
    Date of Patent: September 5, 2000
    Assignee: Trigen Limited
    Inventors: Goran Claeson, Manfred Hans Wilhelm Phillip
  • Patent number: 5856306
    Abstract: Pharmaceutical compositions comprising compounds of the formula: ##STR1## in which X.dbd.H or is an N-protecting group; Y is 1-10 .alpha.-amino acids; Q1 and Q2 taken together represent the residue or a diol; R is C.sub.1-4 alkyl; and the asymmetric carbon atom marked * may have the D- or L-configuration, are useful in therapeutic methods of inhibiting thrombin.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: January 5, 1999
    Assignee: Trigen, Limited
    Inventors: Goran Claeson, Manfred Hans Wilhelm Philipp, Rainer Metternich
  • Patent number: 5574014
    Abstract: Pharmaceutical compositions comprising compounds of the formula: ##STR1## in which X=H or is an N-protecting group; Y is Phe-Pro; Q1 and Q2 taken together represent the residue of a diol; R is C.sub.1-4 alkyl; and the asymmetric carbon atom marked * may have the D- or L- configuration, are useful in therapeutic methods of inhibiting thrombin.
    Type: Grant
    Filed: May 10, 1994
    Date of Patent: November 12, 1996
    Assignee: Thrombosis Research Institute
    Inventors: Goran Claeson, Manfred H. W. Philipp, Rainer Metternich